Gadget that shines bright red LEDs to mend cancer scars now being used to treat debilitating scarring and swelling in the mouth caused by radiotherapy
The therapy - known as photobiomodulation - is being offered to NHS patients in Nottingham, where experts claim it has proved remarkably successful. (Source: the Mail online | Health)
Source: the Mail online | Health - February 25, 2024 Category: Consumer Health News Source Type: news

New cancer therapy approved by FDA supercharges body ’s immune system
After undergoing surgery, radiation and three different therapies, Scott Goedeke faced a tough reality: The cancer that first surfaced on the roof of his mouth had spread to a lymph node in his neck. So the 58-year-old health-care consultant agreed to an experimental treatment that would deploy…#scottgoedeke #sitemancancercenter #stlouis #fda #steverosenberg #iovance #frederickvogt #jasonbock #ctmc (Source: Reuters: Health)
Source: Reuters: Health - February 21, 2024 Category: Consumer Health News Source Type: news

Do we recognize oral cancer? Primary professional delay in diagnosis of oral squamous cell carcinoma
ConclusionsOSCC patients seek care actively. Primary professional delay affects the care of every tenth OSCC patient.Clinical relevanceThe role of health care professionals is essential for early OSCC diagnosis, especially in urgent care. Clinicians ’ knowledge of the typical symptoms and findings of OSCC should be improved. (Source: Dental Technology Blog)
Source: Dental Technology Blog - February 14, 2024 Category: Dentistry Source Type: news

News at a glance: Weird early trees, CERN ’s next big collider, and protecting U.S. gray wolves
PALEONTOLOGY Rare fossil reveals weird early tree The earliest trees, from nearly 400 million years ago, are known mostly from fossils of their trunks; their leaves and canopy shapes have remained a mystery. A newly reported, 350-million-year-old tree found in Canada provides a vivid answer for one such primordial species: As if having a perpetual bad hair day, a thick crown of spiky leaves stuck out perpendicularly from the trunk . Scientists named the tree Sanfordiacaulis densifolia , after the owner of the New Brunswick quarry where they found five specimens. The fossils, amo...
Source: ScienceNOW - February 8, 2024 Category: Science Source Type: news

Why I Stopped Being A “Good” Cancer Patient
“You are allergic to your oral chemotherapy,” explains my oncology team at a recent appointment. “We are going to try a newer drug,” I am on my fourth attempt to find an oral treatment suitable for both my body and my cancer, so that I can maintain a remission that took three years and a stem cell transplant to achieve. “We want to get ahead of it before it gets ahead of us.” In my headphones, Weezer achingly croons, “Say it ain’t so, your drug is a heartbreaker.” [time-brightcove not-tgx=”true”] Since being diagnosed with phase three chronic myeloid leu...
Source: TIME: Health - February 6, 2024 Category: Consumer Health News Authors: Walela Nehanda Tags: Uncategorized freelance Source Type: news

An Experimental Weight-Loss Drug Shows Lasting Results in Early Study
An experimental weight-loss shot from Amgen Inc.—taken less frequently than wildly popular treatments from Eli Lilly & Co. and Novo Nordisk A/S—appears to keep weight off even after patients stop taking it. Patients given a monthly injection of Amgen’s drug, dubbed MariTide, lost up to 14.5% of their body weight in just 12 weeks, according to a small, early-stage study published Monday in the journal Nature Metabolism. And some people kept the weight off for up to 150 days after stopping the drug, findings show. [time-brightcove not-tgx=”true”] “That is really a remarkable and...
Source: TIME: Health - February 5, 2024 Category: Consumer Health News Authors: Madison Muller/Bloomberg Tags: Uncategorized bloomberg wire healthscienceclimate Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales decline
Group salesgrow by 1%1 at constant exchange rates (CER; -7% in CHF), more than offsetting the decline in COVID-19-related sales and biosimilar erosion, and thereby exceeding 2023 guidanceExcluding COVID-19 products,Group sales increase by 8%Pharmaceuticals Divisionsalesincrease by 6% (excluding COVID-19 medicine Ronapreve: +9%) due to ongoing high demand for newer medicines, with eye medicine Vabysmo continuing to be the top growth driver, followed by Ocrevus (multiple sclerosis), Hemlibra (haemophilia A) and Polivy (blood cancer)Diagnostics Division salesare 13% lower due to high demand for COVID-19 tests in 2022; strong ...
Source: Roche Media News - February 1, 2024 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales decline
Group salesgrow by 1%1 at constant exchange rates (CER; -7% in CHF), more than offsetting the decline in COVID-19-related sales and biosimilar erosion, and thereby exceeding 2023 guidanceExcluding COVID-19 products,Group sales increase by 8%Pharmaceuticals Divisionsalesincrease by 6% (excluding COVID-19 medicine Ronapreve: +9%) due to ongoing high demand for newer medicines, with eye medicine Vabysmo continuing to be the top growth driver, followed by Ocrevus (multiple sclerosis), Hemlibra (haemophilia A) and Polivy (blood cancer)Diagnostics Division salesare 13% lower due to high demand for COVID-19 tests in 2022; strong ...
Source: Roche Investor Update - February 1, 2024 Category: Pharmaceuticals Source Type: news

Zydus launches pill for prostate cancer patients
The drug firm said the medication would cost Rs 6,995 per month, which is 50 per cent less than the currently available injectable options. "With this, the treatment for prostate cancer in India can now be made completely oral, thus helping patients lead a better quality of life," Zydus Lifesciences said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 30, 2024 Category: Pharmaceuticals Source Type: news

' Brush Biopsy' Could Be Easy Dental Office Cancer Screen
MONDAY, Jan. 22, 2024 -- A newly developed “brush biopsy” allows dentists to screen for the most common form of mouth cancer, a new study reports.Dentists use a small brush to gently collect cells from potentially cancerous lesions inside the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 22, 2024 Category: General Medicine Source Type: news

Artificial intelligence for classification and detection of oral mucosa lesions on photographs: a systematic review and meta-analysis
ConclusionsAI may assist in oral mucosa lesion screening while the expected accuracy gains or further health benefits remain unclear so far.Clinical relevanceArtificial intelligence assists oral mucosa lesion screening and may foster more targeted testing and referral in the hands of non-specialist providers, for example. So far, it remains unclear if accuracy gains compared with specialized can be realized. (Source: Dental Technology Blog)
Source: Dental Technology Blog - January 18, 2024 Category: Dentistry Source Type: news

Independent Research Data On Hepatic Artery Infusion (HAI) Therapy To Be Featured At ASCO GI Cancer Symposium
Researchers from several top academic medical institutions will present their findings related to HAI therapy through live presentations, oral abstracts, and posters at the symposium. BOSTON, Jan. 16, 2024 /PRNewswire-PRWeb/ -- Intera Oncology, maker of the only FDA-approved implantable... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 16, 2024 Category: Pharmaceuticals Tags: TRI TDS Source Type: news

Revealed: How to check your OWN mouth for signs of cancer
Dr Michael Ho, a face, neck and mouth cancer consultant at the University of Leeds, shares his step-by-step guide of the signs to check for. (Source: the Mail online | Health)
Source: the Mail online | Health - January 13, 2024 Category: Consumer Health News Source Type: news

Prior Auth Tied to Delays, Discontinuation of Cancer Meds Prior Auth Tied to Delays, Discontinuation of Cancer Meds
The introduction of a new prior authorization requirement for an established oral anticancer regimen led to more treatment delays and discontinuations among Medicare beneficiaries.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 4, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news

BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form
It is a more patient-friendly way to tackle prostate cancer. It can help improve patient compliance to a great extent, Badiger said. The company said introducing the Drug Controller General of India (DCGI)approved new drug delivery system will make it more affordable and accessible in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 2, 2024 Category: Pharmaceuticals Source Type: news